How to Interpret Liver Function Test Results

TL;DR

Liver function tests help distinguish hepatocellular injury, cholestasis, hyperbilirubinemia, and impaired hepatic function. Marked AST and ALT elevations suggest hepatocyte injury, while alkaline phosphatase, GGT, and bilirubin elevations point toward impaired bile flow or biliary injury. Bilirubin fractionation and protein synthesis markers, including albumin and prothrombin time, further clarify the underlying pattern.

Transcript

what's up Ninja nerds in this video today we're going to be talking about liver function test that's also known as lfts again this is a part of our clinical medicine section and I really hope that you guys are liking these videos I really hope they're making sense and they're really helping you to understand the topic really well and if they do ple... Read More

Key Insights

• Liver function tests are more accurately viewed as liver biochemical tests because they provide information about hepatic function as well as hepatobiliary injury. Their interpretation includes enzyme elevations, bilirubin patterns, and protein synthesis markers rather than relying on a single measurement.
• AST and ALT are intracellular hepatocyte enzymes that enter the bloodstream when hepatocytes are damaged. Marked elevations therefore indicate a hepatocellular injury pattern, although the biochemical pattern alone does not establish the specific cause of the injury.
• Hepatocyte injury can result from several processes described in the lecture, including direct damage from drugs or toxins, hepatic artery damage, hepatic vein damage, and biliary duct obstruction. These mechanisms can all contribute to increased AST and ALT levels.
• Cholestasis is decreased movement of bile through the biliary system into the small intestine. It may be intrahepatic, involving impaired secretion or biliary injury within the liver, or extrahepatic, involving an obstruction that causes bile components to back up.
• Alkaline phosphatase, GGT, and bilirubin are key indicators of a cholestatic pattern. Their elevations can reflect impaired bile excretion by hepatocytes, increased enzyme expression after biliary cell injury, or obstruction of bile flow outside the liver.
• Bilirubin begins as unconjugated, or indirect, bilirubin released after macrophages consume red blood cells. Hepatocytes take it up, and the UGT enzyme adds glucuronate, converting it into conjugated, or direct, bilirubin before biliary transport.
• Hyperbilirubinemia is classified by determining whether indirect bilirubin, both bilirubin fractions, or primarily direct bilirubin is elevated. This distinction helps organize the diagnostic evaluation by locating where bilirubin processing or movement may be disrupted.
• Hepatic function assessment includes protein synthesis markers such as albumin and prothrombin time. These measurements complement injury markers because AST, ALT, alkaline phosphatase, GGT, and bilirubin primarily reveal biochemical patterns of hepatobiliary damage or impaired bile handling.

Questions & Answers

Q: What do liver function tests measure?

Liver function tests provide information about both hepatic function and hepatobiliary injury, which is why the lecture also calls them liver biochemical tests. Their components include AST and ALT, bilirubin, alkaline phosphatase, GGT, albumin, and prothrombin time. Together, these measurements help identify hepatocellular damage, cholestasis, hyperbilirubinemia, and abnormalities involving the liver's protein synthesis function.

Q: How do AST and ALT indicate hepatocellular injury?

AST and ALT are molecules or enzymes located inside hepatocytes. When hepatocytes experience direct or indirect injury, their cellular contents leak into the bloodstream, producing elevated laboratory values. A marked rise in AST and ALT therefore supports a hepatocellular injury pattern. The lecture links such injury to drugs, toxins, hepatic artery damage, hepatic vein damage, and biliary duct obstruction.

Q: What is cholestasis in liver test interpretation?

Cholestasis is decreased movement of bile through the biliary system into the small intestine. Intrahepatic cholestasis involves impaired bile secretion or biliary cell injury within the liver. Extrahepatic cholestasis occurs when an obstruction outside the liver impairs bile flow, causing bile and related biochemical markers to back up and enter the bloodstream rather than moving normally into the intestine.

Q: Which liver test results suggest cholestasis?

Elevated alkaline phosphatase, GGT, and bilirubin suggest a cholestatic pattern. When hepatocytes cannot excrete bile normally, bile accumulates within them and bilirubin can move into the bloodstream. Injury to hepatocytes or biliary cells can also increase alkaline phosphatase and GGT expression. An obstruction outside the liver may produce similar elevations by causing progressive backup through the biliary system.

Q: What is the difference between intrahepatic and extrahepatic cholestasis?

Intrahepatic cholestasis occurs when bile does not move properly within the liver, such as when hepatocytes fail to excrete it or biliary duct cells are injured. Extrahepatic cholestasis involves an obstruction outside the liver that blocks bile from reaching the small intestine. Both processes can cause bilirubin, alkaline phosphatase, and GGT to accumulate in the bloodstream.

Q: How is unconjugated bilirubin converted into conjugated bilirubin?

Macrophages consume red blood cells and release unconjugated bilirubin, also called indirect bilirubin, into the bloodstream. Hepatocytes then take up this bilirubin. An enzyme called UGT adds glucuronate, converting it into conjugated bilirubin, also called direct bilirubin. The conjugated bilirubin is transported into the bile system and then moves toward the small intestine.

Q: How are different patterns of hyperbilirubinemia classified?

Hyperbilirubinemia is classified by identifying which bilirubin fraction is elevated. An unconjugated pattern primarily raises indirect bilirubin. A mixed pattern includes meaningful elevations of both unconjugated and conjugated bilirubin. A predominantly conjugated pattern mainly raises direct bilirubin. Distinguishing these patterns helps structure the diagnostic approach by showing which stage of bilirubin production, conjugation, or transport may be affected.

Q: When should liver function tests be considered?

Liver function tests should be considered when a patient presents with findings that may indicate hepatobiliary disease, including jaundice, right upper quadrant abdominal pain, or fulminant encephalopathy. The results can then be organized around evidence of hepatocellular injury, cholestasis, hyperbilirubinemia, or impaired hepatic function. This pattern-based approach helps guide the subsequent diagnostic evaluation for liver disease.

Summary & Key Takeaways

• Liver function tests are better understood as liver biochemical tests because they evaluate both hepatic function and hepatobiliary injury. They are useful when assessing presentations such as jaundice, right upper quadrant abdominal pain, or fulminant encephalopathy. Interpretation begins by identifying the dominant biochemical pattern rather than viewing every abnormal result identically.

• Hepatocellular injury produces prominent elevations of AST and ALT because damaged hepatocytes release these intracellular enzymes into the bloodstream. Injury may relate to drugs, toxins, hepatic arterial damage, hepatic venous damage, or biliary obstruction. The diagnostic process uses the enzyme pattern to guide evaluation of possible liver diseases and causes.

• Cholestasis reflects decreased bile movement and may arise inside or outside the liver. Alkaline phosphatase, GGT, and bilirubin can accumulate when bile secretion fails, biliary cells are injured, or an obstruction causes backup. Bilirubin fractionation then distinguishes unconjugated, mixed, and predominantly conjugated hyperbilirubinemia patterns for further diagnostic evaluation.